Evidence map›Paper›PMID 23508604›Full record

ArticleAnnals of family medicine

Risks and benefits associated with antibiotic use for acute respiratory infections: a cohort study.

Sharon B Meropol, A Russell Localio, Joshua P Metlay

Open access · diamondAbstract readComparative Study
In one paragraph

Article in Annals of family medicine. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 3 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 3 syntheses or guidelines pooled it, 49 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Review
  11. Observational
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Antimicrobial stewardship - can we afford to do without it?British journal of clinical pharmacology · 2015
    Article
  20. Antibiotic stewardship.Clinical medicine (London, England) · 2013
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Sharon B MeropolDepartment of Pediatrics, Case Western Reserve University School of Medicine, Cleveland, OH, USA.
A Russell Localio
Joshua P Metlay
University of Pennsylvania · US

Funding

INSTITUTIONAL CLINICAL AND TRANSLATIONAL SCIENCE AWARDUL1RR024134 · NCRR · UNIVERSITY OF PENNSYLVANIA · PI FITZGERALD, GARRET A · 2006 to 2011
$70.4M
Center For Education and Research in TherapeuticsU18HS016946 · AHRQ · UNIVERSITY OF PENNSYLVANIA · PI STROM, BRIAN LESLIE · 2007 to 2010
$4.0M
Neighborhood level determinants of pneumococcal disease transmissionK24AI073957 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI METLAY, JOSHUA P · 2008 to 2012
$1.0M
Antibiotic Use and Adverse EventsF32AI073015 · NIAID · UNIVERSITY OF PENNSYLVANIA · PI MEROPOL, SHARON B · 2007 to 2009
$220k
AHRQ HHS U18 HS016946NCRR NIH HHS UL1 RR024134NCRR NIH HHS UL1-RR02-4134NIAID NIH HHS F32 AI073015NIAID NIH HHS F32-AI-073015NIAID NIH HHS K24 AI073957
6 · The paper itself

Abstract

purposeAntibiotics are frequently prescribed for acute nonspecific respiratory infections (ARIs), presumably to avoid small risks of progression to serious bacterial illness. However, even low risks of associated adverse drug events could result in many such events at the population level. Our objective was to assess the risks and benefits of antibiotic use in a cohort of patients with ARIs, comparing outcomes of patients who were prescribed antibiotics with outcomes of patients not receiving antibiotics.

methodsWe used a June 1986 to August 2006 cohort of adult patients with ARI visits from a UK primary care database. Exposure was an antibiotic prescribed with the visit. Primary outcomes were hospitalization within 15 days for (1) severe adverse drug events (hypersensitivity, diarrhea, seizure, arrhythmia, hepatic or renal failure), and (2) community-acquired pneumonia.

resultsThe cohort included 1,531,019 visits with an ARI diagnosis; prescriptions for antibiotics were given in 65% of cases. The adjusted risk difference for treated vs untreated patients per 100,000 visits was 1.07 fewer adverse events (95% CI, -4.52 to 2.38; P = .54) and 8.16 fewer pneumonia hospitalizations (95% CI, -13.24 to -3.08; P = .002). The number needed to treat to prevent 1 hospitalization for pneumonia was 12,255.

conclusionsCompared with patients with ARI who were not treated with antibiotics, patients who were treated with antibiotics were not at increased risk of severe adverse drug events and had a small decreased risk of pneumonia hospitalization. This small benefit from antibiotics for a common ambulatory diagnosis creates persistent tension; at the societal level, physicians are compelled to reduce antibiotic prescribing, thus minimizing future resistance, whereas at the encounter level, they are compelled to optimize the benefit-risk balance for that patient.

Indexed as

Acute DiseaseAdultAnti-Bacterial AgentsCommunity-Acquired InfectionsFemaleHospitalizationHumansMaleMedical RecordsMiddle AgedOutcome Assessment, Health CarePneumonia, BacterialPrimary Health CareRespiratory Tract InfectionsRetrospective StudiesRisk AssessmentAnti-Bacterial Agents

Identifiers

PMID23508604
PMCPMC3601395
OpenAlexW2098999044

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.